COVID-19 in the Critically Ill: Too Risky for High-Dose Anticoagulation?

Chest. 2021 Aug;160(2):e249. doi: 10.1016/j.chest.2021.03.028.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / adverse effects
  • Blood Coagulation
  • COVID-19*
  • Critical Illness*
  • Humans
  • SARS-CoV-2

Substances

  • Anticoagulants